Professor Tobias Welte, a scientist at the German Center for Lung Research (DZL) and the German Center for Infection Research (DZIF), died on Sunday after a short, serious illness. We are deeply
New active substances for the treatment of resistant bacteria are needed more urgently than ever – yet only few candidates make the leap from research to clinical application. To facilitate precisely
TherVacB, a novel therapeutic vaccine to combat chronic hepatitis B, entered the first clinical trial. The vaccine was designed and developed under the leadership of Helmholtz Munich. This phase Ia
Tuberculosis and malaria are among the deadliest infectious diseases worldwide and are increasingly spreading, not least due to climate change. In both cases, antimicrobial resistance renders
The wave of protests against right-wing extremism, with demonstrations in many different locations in Germany, has been going on for around a month. This was triggered by disclosures made by the
A recent clinical study shows that ganfeborole could be a promising candidate for the safe and effective treatment of pulmonary tuberculosis. Using microbiological testing and innovative imaging
The German Federal Ministry of Health (BMG) has appointed new members to the Standing Committee on Vaccination (STIKO). Among the 19 experts is Dr Berit Lange, acting head of the department
"How can we support our Ukrainian partners in times of war?"—This was the question posed by DZIF scientist Professor Christoph Lange and his colleagues from the Research Center Borstel, Leibniz Lung
The International Day of Women and Girls in Science is celebrated every year on 11 February. Women are still underrepresented worldwide and particularly in the German science system: at 29.4 per cent
The INCubator for Antibacterial Therapies in Europe, INCATE, aims to support innovators in the early stages of developing therapies in the field of antimicrobial resistance. The German Center for
